<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR30">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Green</surname>
    <given-names>DM</given-names>
   </name>
   <name>
    <surname>Nolan</surname>
    <given-names>VG</given-names>
   </name>
   <name>
    <surname>Goodman</surname>
    <given-names>PJ</given-names>
   </name>
   <name>
    <surname>Whitton</surname>
    <given-names>JA</given-names>
   </name>
   <name>
    <surname>Srivastava</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Leisenring</surname>
    <given-names>WM</given-names>
   </name>
   <name>
    <surname>Neglia</surname>
    <given-names>JP</given-names>
   </name>
   <name>
    <surname>Sklar</surname>
    <given-names>CA</given-names>
   </name>
   <name>
    <surname>Kaste</surname>
    <given-names>SC</given-names>
   </name>
   <name>
    <surname>Hudson</surname>
    <given-names>MM</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the childhood Cancer survivor study</article-title>
  <source>Pediatr Blood Cancer</source>
  <year>2014</year>
  <volume>61</volume>
  <issue>1</issue>
  <fpage>53</fpage>
  <lpage>67</lpage>
  <pub-id pub-id-type="doi">10.1002/pbc.24679</pub-id>
  <pub-id pub-id-type="pmid">23940101</pub-id>
 </element-citation>
</ref>
